Beijing Chunlizhengda Medical Instruments Co., Ltd. (“Chunli Medical”) has completed the first meeting of its sixth Board session on 25 June 2026, confirming a comprehensive leadership transition and committee re-organisation.

Key decisions approved by poll include:

1. Board Chairmanship • Ms. Shi Wenling has been elected Chairman of the sixth Board, effective immediately upon approval.

2. Board Committee Line-up • Audit Committee – Chair: Ms. Xu Hong; Members: Mr. Wang Xin, Mr. Zheng Zhong Liang, Mr. Kwan King Nam. • Remuneration Committee – Chair: Mr. Zheng Zhong Liang; Members: Ms. Shi Wenling, Ms. Xu Hong. • Nomination Committee – Chair: Ms. Xu Hong; Members: Ms. Yue Shujun, Mr. Zheng Zhong Liang. • Strategic Committee – Chair: Mr. Shi Chunbao; Members: Ms. Shi Wenling, Mr. Xie Feng Bao, Mr. Wang Xin.

All appointments take effect from the Board’s approval date. The company’s executive directors now comprise Ms. Shi Wenling, Mr. Shi Chunbao, Ms. Yue Shujun and Mr. Xie Feng Bao; the non-executive director is Mr. Wang Xin; and independent non-executive directors are Ms. Xu Hong, Mr. Zheng Zhong Liang and Mr. Kwan King Nam.

The Board expressed its welcome to the appointees and confirmed no changes to previously disclosed biographical information.